Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis
Given the vast number of cystic fibrosis transmembrane conductance regulator ( ) mutations, biomarkers predicting benefit from CFTR modulator therapies are needed for subjects with cystic fibrosis (CF). To study CFTR function in organoids of subjects with common and rare mutations and evaluate corre...
Saved in:
Published in | The European respiratory journal Vol. 57; no. 1; p. 1902426 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.01.2021
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!